Market Dashboard
S&P 500 equity research overview
Top Momentum
View AllSector Distribution
Momentum Score Distribution
Recent Research Reports
ABBV Equity Research Report
AbbVie represents a compelling dividend-focused pharmaceutical investment with consistent earnings outperformance and strong fundamentals despite facing Humira biosimilar headwinds. We recommend **BUY** with a 12-month target price of $260, driven by the successful transition to newer franchises including Skyrizi/Rinvoq, solid pipeline execution, and an attractive 3.04% dividend yield supported by robust cash generation.
ABBV Equity Research Report
AbbVie demonstrates solid momentum with positive returns across all timeframes and maintains its position as a defensive healthcare stalwart trading near historical highs. Despite competitive headwinds in key therapeutic areas, the company's diversified pipeline and strong market position in immunology support a **HOLD** recommendation with a 12-month target price of $235.
Scenario Analysis: Federal reserve cuts rates by .25 basis points
AIG faces headwinds from lower investment returns on its insurance float as interest rates decline, reducing the yield on new bond investments. While the insurer may benefit from some valuation multiple expansion, the fundamental pressure on insurance investment income and net interest margins outweighs these positives.
Scenario Analysis: Federal reserve cuts rates by .25 basis points
Allstate as a property & casualty insurer will be negatively impacted by lower investment returns on its substantial insurance float and reserves. The company's investment income, which is a key component of profitability, will decline as its bond portfolio rolls over into lower-yielding securities.
Scenario Analysis: Federal reserve cuts rates by .25 basis points
Aflac's insurance business model relies heavily on investment returns from its float, which will decline in a lower rate environment as new investments yield less. The company's net interest margins on insurance reserves will compress, negatively impacting profitability despite potential benefits to its equity valuation.
Recent News
Nickel Mining Industry Report 2026: Production by Country, Prices, Companies, Major Operating Mines, Competitive Landscape, Major Exploration and Development Projects 2025-2035
Tennessee Titans Renew Subscription of Evolv Express® at Nissan Stadium
Market Chatter: UK Regulators Press Meta, TikTok, Snap, YouTube to Boost Child Safety Measures
Cramer: Why does Meta need 78,000 employees if AI makes them 10x more productive?
King Salman Park secures $3bn global investor backing for mixed-use district
GURU Organic Energy Reports Record Q1 Revenue of $8.8 Million and Third Consecutive EBITDA-Positive Quarter
Verano Announces Fourth Quarter and Full Year 2025 Financial Results
Aya Gold & Silver Announces Commencement of Boumadine Feasibility Study and Accelerates Project Development